Article

Working with Partners to Improve Access to Migraine Care

Migraine is a debilitating neurological disorder impacting over a billion people worldwide. At Pfizer, we’re dedicated to understanding the causes of migraine. With that goal in mind, we’ve put together a series of articles exploring different aspects of migraine management.In our first post, we looked at the current state of migraine care, reflecting on what’s working and where there’s room to improve. In the next post, we examined some of the challenges that can prevent people from accessing...

Patrick Dempsey, Pfizer and the American Cancer Society Team Up to “Change the Odds” Against Cancer

For award-winning actor and cancer community advocate Patrick Dempsey, working to help make sure everyone has the same opportunity to prevent, detect and treat cancer is deeply personal. Being by his mother’s side during her 17-year journey with ovarian cancer, Patrick experienced the profound impact that a cancer diagnosis can have on both a patient and their family. It was this experience that led him to create The Dempsey Center, a non-profit which offers a space where people navigating...

Science & Innovation

What You Need to Know About a Promising Vaccine Candidate that May Stem the Growing Risk of Lyme Disease

Lyme disease is the most common vector-borne illness in the United States.1 The U.S. Centers for Disease Control and Prevention (CDC) says that state health departments reported over 63,000 cases in 2022.2 However, the CDC uses other methods to estimate that approximately 476,000 people in the U.S. may be diagnosed and treated for Lyme disease annually.2In other words, the estimated number of Lyme disease cases in the U.S. seems to be much higher than what is being reported to public health...

Purpose & Ideals

Global Health Fellows: Partnering to Strengthen Health Systems

Recently, Ellen Gerstein, Pfizer's Senior Director of Digital Communications, visited Africa as part of our Global Fellows Program. She shares her experience in this article.At Pfizer, we’re driven by our Purpose—to deliver breakthroughs that change patients’ lives. That Purpose has never been more clear to me than during my experience partnering with North Star Alliance through Global Health Fellows—Pfizer’s signature skills-based volunteering program.Since 2003, Global Health Fellows has...

Opportunities to Drive Change in Alopecia Areata

A disease doesn’t have to be life-threatening to be life changing. Alopecia areata (AA), an autoimmune disease that causes hair loss, typically on the head and face, is a perfect example.AA affects 2% of the global population, but a variety of factors, including a lack of awareness, challenges in its diagnosis, and stigmas surrounding it, especially around the myth that it’s cosmetic versus an autoimmune disease, make clear that there is a critical need for education and improved management of...

Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism

Left to right: Dave Denton and Pfizer colleagues packing “Cheer kits” for veterans in the New York regionBuilding on Pfizer’s 175-year legacy to be a force for good in the world, Pfizer has launched 175 Days of Good—a global call to action to inspire and celebrate colleague volunteerism and Pfizer’s collective commitment to do good where we work, live—and beyond.From June 13 to International Volunteer Day on December 5, Pfizer colleagues around the world are hosting and joining volunteer events...

Purpose & Ideals

An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries

Currently, regulatory agencies may take up to seven years to approve essential medicines and vaccines in low- and middle-income counties (LMICs) from the time those same treatments were first approved in high-income countries, if they are approved at all.1 The burden remains disproportionately higher in low-income countries.2 Lack of access to quality healthcare is related to healthcare inequities in LMICs and hinders equitable access to safe and effective treatments.2Those living in LMICs...

Programs & Initiatives

Pfizer's Multicultural Health Equity Collective Marks 10 Years of Progress

Marginalized communities in the United States have faced generations of health inequities due to systemic discrimination embedded into our healthcare system. Life expectancy in the U.S., for instance, masks significant racial and ethnic disparities – the average life expectancy for non-Hispanic American Indians or Alaska Natives is seven years lower than it is for non-Hispanic whites.1

Pfizer Celebrates Legacy, Justice, and Equity

Pfizer colleagues reflected on the significance of the Martin Luther King, Jr holiday and Black History Month with a series of events organized by members of Pfizer’s Global Black Community (GBC). These events, which included discussions, panels, and community-based gatherings, embraced the legacy of Dr. Martin Luther King Jr., and paid tribute to those who have helped shape the past, present, and future of the Black community, guided by principles of justice, equity, and inclusion.The...

“Change the Odds” Brings Pfizer Together with the American Cancer Society to Bridge the Gap in Cancer Care Disparities

Pfizer has long been committed to the research and development of innovative cancer treatments for patients around the world. This commitment was further strengthened by the addition of Seagen, a world leader in a powerful cancer-fighting tool called antibody-drug conjugates, enabling us to be at the forefront of cancer care. Additionally, addressing inequities in the healthcare of patients is one of Pfizer’s top priorities, and we’re proud to announce a new initiative that incorporates both of...

Trusted Voices

Together We Can Change the Odds for People with Cancer

One in three people in the United States will receive a cancer diagnosis in their lifetime.i This means you, or someone you know, may someday be impacted. This disease does not discriminate. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support.  To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing...

Pfizer Awards $2M to Nonprofit Organizations Addressing Systemic Health Inequities

video-js.video-js.vjs-fluid:not(.vjs-audio-only-mode) { padding-top: 56.25%; } Equity is a core value at Pfizer, and we have a longstanding commitment to helping resolve deeply ingrained systemic health inequities. To make better health possible for everyone, everywhere, we develop programs and embark on partnerships that help educate, include, and reach communities that have been historically overlooked.One of those programs – the ‘Communities in Action for Health Equity’ grant...